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Abstract: Seven macrocyclic dinuclear Cu(II) complexes with tpmc = 
= N,N',N",N'"-tetrakis(2-pyridylmethyl)-1,4,8,11-tetraazacyclotetradecane of 
coordination formulae [Cu2tpmc](ClO4)4 (1), [Cu2(X)tpmc](ClO4)3·nH2O, 
X= F-, n = 0 (2), X = Cl-, n = 1 (3), X = Br-, n = 0 (4), X= I-, n = 1 (5), X = 
= NO2-, n = 0 (6), [Cu2(NCS)2tpmc](ClO4)2 (7) were evaluated for their cyto-
toxic activity against human cervix adenocarcinoma (HeLa), human melanoma 
(Fem-x) and human colon carcinoma (LS174) cell lines. The results were 
compared with the corresponding data for the cis-diamminedichloridopla-
tinum(II) (CDDP) as referent cytostatic, as well as with the free ligands and the 
solvent dimethyl sulfoxide (DMSO) as controls. The complexes showed con-
siderable antiproliferative effect, although significantly less than CDDP. The 
thermal decomposition pattern of the complexes was determined by simul-
taneous TG/DSC measurements. The thermal stability of the compounds 2–7 
followed the trend of their antiproliferative activity against the HeLa cell line, 
as well as their corresponding stability constants. The highest thermal stability 
and cytotoxicity belonged to complex [Cu2tpmc](ClO4)4, with no anionic co-
ligand. Complex [Cu2(NO2)tpmc](ClO4)3 exhibited a selective cytotoxicity 
against LS174 cells, at the level of the most active [Cu2tpmc](ClO4)4. 
Keywords: copper(II)complexes; octaazamacrocycle; antiproliferative activity; 
thermal analysis. 
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INTRODUCTION 
The coordination chemistry of macrocyclic ligands has attracted much atten-
tion.1 Macrocyclic ligands coordinated with metal ions give stable complexes of 
different structures, and different catalytic, redox, etc. characteristics. They are 
applied as antitumor,2 antiviral (including HIV activity),3,4 antibacterial, antifun-
gal or antimalarial agents.5–10 The clinical success of cisplatin in the treatment of 
several human malignant tumors motivated major research efforts toward the 
discovery of alternative metal complexes with potential anticancer activity11,12 
but with fewer side effects. Copper is a physiologically important metal that 
plays a significant role in endogenous oxidative DNA damage associated with 
aging and cancer.13 For the past several decades, great effort has been devoted to 
binding studies of copper complexes with DNA.14–16 In particular, many studies 
were focused on binuclear copper complexes due to their presence in metallopro-
teinase as well as their affinity for DNA.17–22 
The ligand N,N',N'',N'''-tetrakis(2-pyridylmethyl)-1,4,8,11-tetraazacyclotet-
radecane (tpmc) has four pendant arms that could participate in coordination with 
metal ions.23 Depending on the metal centre, the structure and the number of co-
ligand(s), it forms mono-, bi- or tetra-nuclear complexes. Metal centers linked to 
tpmc are either exo or endo, or may be bridged with additional ligands or bound 
in the trans position (one for each metal ion). Numerous complexes containing 
various co-ligands have been previously described.24–29 
The aim of this study was to investigate the potential antiproliferative acti-
vity of seven macrocyclic binuclear Cu(II) complexes with or without co-ligands 
with the formulas: [Cu2tpmc](ClO4)4 (1), [Cu2(X)tpmc](ClO4)3·nH2O, X = F–, 
n = 0 (2), X = Cl–, n = 1 (3), X = Br–, n = 0 (4), X = I–, n = 1 (5), X = NO2–, n = 0 
(6), [Cu2(NCS)2tpmc](ClO4)2 (7), which were earlier described.30 
Thermal stability may be crucial in assessing the applicability of new com-
pounds. Due to this, the thermal behavior of the ligand and the complexes are 
discussed in details in this article. 
EXPERIMENTAL 
Chemicals and materials 
Macrocyclic ligand (tpmc),31 Cu(ClO4)2⋅6H2O,32 complex 1 ([Cu2tpmc](ClO4)4)30a and 
complexes 2–7 ([Cu2(X)tpmc](ClO4)3·nH2O, X = F-, n = 0 (2), X = Cl-, n = 1 (3), X = Br-, n = 0 
(4), X = I-, n = 1 (5), X = NO2-, n = 0 (6), [Cu2(NCS)2tpmc](ClO4)2 (7))30b were obtained and 
purified according to literature procedures*. All other chemicals were of p.a. grade and were 
used as supplied, except for recording electronic spectra, when acetonitrile (MeCN) for HPLC 
was used.  
                                                                                                                    
* Warning: perchlorate salts of metal complexes with organic ligands are potentially explosive 
and should be stored and handled with great caution!  
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Antiproliferative assay 
Human cervix adenocarcinoma (HeLa), human melanoma (Fem-x) and human colon 
carcinoma (LS174) cell lines were obtained from the American Type Culture Collection 
(Manassas, VA, USA). All cancer cell lines were maintained in the recommended RPMI-1640 
medium supplemented with 10 % heat-inactivated (56 °C) fetal bovine serum, L-glutamine 
(3 mM), streptomycin (100 mg mL-1), penicillin (100 IU mL-1), 25 mM HEPES and adjusted 
to pH 7.2 with bicarbonate solution. Cells were grown in a humidified atmosphere of 95 % air 
and 5 % CO2 at 37 °C. Stock solutions (10 mM) of the compounds, made in DMSO, were 
dissolved in the corresponding medium to the required working concentrations. Neoplastic 
HeLa cells (2000 cells per well), Fem-x cells (5000 cells per well) and LS174 cells (7000 cells 
per well) were seeded into 96-well microtiter plates, and 24 h later, after cell adherence, five 
different, double diluted concentrations of the investigated compounds were added to the 
wells. The final concentrations applied to the target cells were: 200, 100, 50, 25 and 12.5 μM, 
except to the control wells, where only nutrient medium was added. The cultures were 
incubated for 72 h. The effect of compounds on cancer cell survival was determined by the 
MTT test according to Mosmann,33 with modification by Ohno and Abe,34 72 h upon addition 
of the compounds, as was described earlier. Briefly, 20 μL of MTT solution (5 mg mL-1 PBS) 
were added to each well. The samples were incubated for a further 4 h at 37 °C in a 5 % CO2 
humidified air atmosphere. Then, 100 μL of 10 % SDS were added to extract the insoluble 
product formazan, resulting from the conversion of the MTT dye by viable cells. The number 
of viable cells in each well was proportional to the intensity of the absorbance of light, which 
was then read in an ELISA plate reader at 570 nm. Absorbance (A) at 570 nm was measured 
24 h later. To obtain cell survival (%), the A of a sample with cells grown in the presence of 
various concentrations of the investigated extracts was divided by the control optical density 
(the A of control cells, grown only in nutrient medium), and multiplied by 100. Absorbance, 
of the blank, As, was subtracted from the absorbance of the treated cells, At, of the corres-
ponding sample with target cells. Concentration IC50 was defined as the concentration of an 
agent inhibiting cell survival by 50 %, compared with a vehicle-treated control. All experi-
ments were performed in triplicate. The cell survival (S) was calculated by the equation: 
 t s
c s
( ) (%) 100
( )
A АS
A A
−
=
−
 
where Ac is the absorbance of the control.  
Thermal analysis 
Thermogravimetric (TG) measurements were performed on a simultaneous TGA/DSC 
thermal analyzer Q600 SDT (TA Instruments) using open alumina sample pans and the 
corresponding empty reference pan in a dynamic nitrogen atmosphere (flow rate: 100 cm3 
min-1). Sample mass: ≈1 mg; heating rate: 20 °C min-1 and temperature range: up to 500 °C. 
For the evolved gas analysis (TGA/DTA–MS), an SDT 2960 Simultaneous TGA/DTA (TA 
Instruments Inc.) thermal analyzer and a Thermostar GSD 200 (Balzers Instruments) 
quadrupole mass spectrometer were coupled. Measurements data: open platinum crucible, 
m ≈ 2 mg, heating rate: 10 °C min-1, heated capillary connection (t = 200 °C, methyl 
deactivated fused silica capillary tube, φ = 0.15 mm). 
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RESULTS AND DISCUSSION 
Binuclear Cu(II) complexes 1–7 were prepared and purified according to 
described procedures.30 All the tested Cu(II) complexes are binuclear wherein 
the macrocycle is exo-bonded to the metal ions. The structure of the tpmc ligand 
is presented in Scheme 1 while the structures of selected complexes are presented 
in Scheme 2a–c. As can be seen, each Cu(II) is coordinated to two nitrogen 
atoms of the cyclam ring and to two nitrogens from the two 2-pyridylmethyl 
groups of the macrocyclic ligand. For complexes 1 and 7 (Scheme 2a and c), the 
chair conformation was found.30 In 7, an NCS– ligand is bonded in the trans 
position to each copper(II) ion (Scheme 2c). In complexes 2–6, only one mono-
valent anion is coordinated to the binuclear complex cations. Due to the coordi-
nated co-ligand anions, the complex cations have different charges: 4+ in 1, 3+ in 
complexes 2–6 and 2+ in 7. For complexes with F– (2) and Cl– (3) co-ligands, 
X-ray analysis confirmed the bridged coordination of the fluoride and chloride 
with Cu(II) that is exo-coordinated with respect to the cyclam ring in the boat 
conformation (Scheme 2b).30b For the complexes containing Br–, I– and NO2–, 
the same coordination mode is proposed based on their analytic data, and physi-
cal and chemical properties.30b 
 
Scheme 1. Ligand N,N',N'',N'''-tetrakis(2- 
-pyridylmethyl)-1,4,8,11-tetraazacyclotetra-
decane (tpmc). 
The in vitro antiproliferative activity of the compounds 1–7, tpmc, 
Cu(ClO4)2·6H2O, co-ligands 2a–7a and DMSO was tested against HeLa, Fem-x 
and LS174 cell lines and with cis-diamminedichloridoplatinum(II) (CDDP) as 
the referent cytostatic by the MTT colorimetric assay method. The IC50 values of 
the complexes were in the range 17.7–133.4 μM for the Cu(II) complexes against 
all the tested cell lines, while they were in the range 2.1–7.8 µM for CDDP. The 
tpmc ligand, Cu(ClO4)2·6H2O and the free co-ligands showed significantly lower 
activity (IC50 > 200 µM).  
The order of sensitivity of various cell lines to antiproliferative action of the 
complexes was cervix adenocarcinoma HeLa > colon carcinoma LS174 > mela-
noma Fem-x. In contrast, ligands used in doses from 0–200 µM were ineffective 
(IC50 > 200 µM) against the same cell lines. Only 2a showed a moderate anti-
proliferative activity against all the tested lines, while 3a, 4a and 7a exhibited 
very weak activity against HeLa cells. Generally, complexes 1–7 showed marked 
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effects compared to those of the ligands. Complex 1 showed remarkable cytotox-
icity towards all three cell lines (Table I). The cytotoxic curves from the MTT 
assay showing the survival of HeLa, Fem-x and LS174 cells grown for 72 h in 
the presence of increasing concentrations of complexes 1 and 2 are depicted in 
Fig. 1a and b, respectively. 
 
Scheme 2. Structure of the complex cation in the Cu(II) complexes: 1 (a), 2–6, X = F-, Cl-, 
Br-, I- or NO2- (b) and 7 (c). 
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TABLE I. Results of the MTT (IC50 / µM) analysis for Cu(II) tpmc complexes (1–7), 
Cu(ClO4)3·6H2O, free ligand (tpmc), compounds 2a–7a and CDDP; tpmc = N,N',N'',N'''- 
-tetrakis(2-pyridylmethyl)-1,4,8,11-tetraazacyclotetradecane; CDDP = cis-diammine-di-
chloridoplatinum(II) 
Compound HeLa Fem-X LS174 
[Cu2tpmc](ClO4)4 (1) 19.0+0.3 17.7+2.3 22.0+0.5 
[Cu2(F)tpmc](ClO4)3 (2) 35.9±3.0 66.8±2.4 79.2±0.4 
[Cu2(Cl)tpmc](ClO4)3·H2O (3) 46.9±0.4 104.5±2.4 86.0±1.6 
[Cu2(Br)tpmc](ClO4)3 (4) 48.3±2.9 72.9±3.9 75.5±1.4 
[Cu2(I)tpmc](ClO4)3 (5) 45.0±3.4 79.0±1.9 57.9±0.2 
[Cu2(NO2)tpmc](ClO4)3 (6) 51.4±4.1 133.4±4.0 22.1±0.2 
[Cu2(NCS)2tpmc](ClO4)2 (7) 61.0±0.9 103.5±0.6 51.8±0.1 
Cu(ClO4)2·6H2O, tpmc >200 >200 >200 
NaF (2a) 91.5±1.0 76.5±4.1 148.3±6.1 
NaCl (3a) 186.2±3.8 >200 >200 
KBr (4a) 186.9±1.3 >200 >200 
KI (5a) NaNO2 (6a) >200 >200 >200 
KSCN (7a) 108.5±4.0 >200 >200 
CDDP 2.1±0.2 3.2±0.4 7.8±0.3 
Complex 2 had the highest activity against the HeLa cell line. Complexes 3–6 
showed decreasing activity in the series I– > Cl– > Br– > NO2–. The order of the 
cytotoxicity of the complexes in the case of the HeLa cell line could be related to 
the corresponding stability constants.30b The lowest stability constants exhibited 
5 (with I–, log K = 2.76) and 2 (with F–, log K = 3.03), in agreement with the 
Pearson Theory.35,36 Copper(II), as a transition acid, forms stable complexes 
with transition bases, in the present case with Br–, Cl– and NO2– (log K = 3.77, 
4.80, 4.20, respectively). When comparing the IC50 values for the HeLa cell line, 
it is clear that the least stable complexes had the highest activity, i.e., the com-
plexes with the hardest (F–) and softest (I–) bases acting as co-ligands. The cyto-
toxic effects of the complexes towards Fem-x and LS174 (IC50 55–135 µM) 
were significantly lower than towards the HeLa cell line. An increasing order of 
cytotoxicity was observed with increasing ionic radii going from Cl– to I– in the 
case of LS174 cell line. However, complex 6 with an NO2– co-ligand showed a 
significantly higher activity against LS174 compared to the other complexes in 
all other cell lines. While complex 1 exhibited a rather high cytotoxicity against 
all three cell lines (IC50 18–22 µM), complex 6 had a selective cytotoxicity 
towards the LS174 cell line, comparable with that of 1.  
The cytotoxic effect of the complexes partly originates from their amphi-
philic nature, which bestows on them the capacity to penetrate easily the cell 
membrane. However, the mechanism of the cytotoxicity of the complexes in the 
different cell lines is obviously different and might involve changes in the energy 
or hypoxic status37 in the microenvironment of cancer cell and other factors. 
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Fig. 1. Representative graph showing sur-
vival of HeLa, LS174 and Fem-x cells grown 
for 72 h in the presence of increasing con-
centrations of complexes: a) 1 and b) 2. 
Thermal methods have a special place in the characterization of samples 
with biological activity.38–41 Namely, some of these compounds may be the 
active ingredients of newly developed drugs. Therefore, much attention has been 
paid to the thermal properties of these compounds. 
The thermal decomposition of all the complexes was continuous. As com-
plex 3 is a crystal hydrate, the first change in the TG curve resulted from loss of 
the crystal water. The water evaporation occurred at a steady rate up to the onset 
of complex decomposition at 264 °C. The amount of water lost was more than 
that calculated based on the stoichiometric composition (exp.: ≈3 %, calcd.: 1.73 %). 
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According to the stepwise isothermal (SWI) curve, this mass loss involves at 
least three steps referring to the different characters of the interactions of water or 
to solvent residue (MeCN) within the crystal of 3. Except for 1, the TG curves 
show a small mass loss up to the decomposition temperature in all complexes. 
The mass loss in these compounds may be related to strongly bonded water (< 2 
%) or the consequence of residual solvent. When the samples were kept in a 
desiccator, the hygroscopic water could be partially eliminated. However, in 2, 3 
and 5 some mass loss (< 2 %) was detected even after drying over anhydrous 
CaCl2. By coupled TG–MS measurements, no traces of MeCN were found and 
the mass loss belonged exclusively to water evaporation. It is important to note 
that SWI curves show that on isothermal heating at around 120 °C, all the com-
pounds lost moisture completely.  
The thermal stability of the compounds increased in order of 7 < 6 ≈ 5 < 4 <  
< 3 ≈ 2 < 1 from 203 °C in 7 to 282 °C onset in 1. The decomposition is pre-
sented in Figs. 2 and 3 by the corresponding DTG curves. For all the complexes, 
the decomposition was accompanied by a highly exothermic effect, which was 
expected and is primarily due to the presence of the perchlorate ion. As the 
course of the DSC curves agreed with the course of the corresponding DTG 
curves, only the DTG curves are presented. In compounds with halide ligands, 
the rate of decomposition decreases with decreasing electronegativity of the 
halide. The exothermic effect of the reactions decreased in the same order. The 
decomposition of complexes 2 and 3 (with F– and Cl– co-ligands) is seemingly a 
one-step process. Starting from the bromide complex, fragmentation of the ligand 
 
Fig. 2. DTG curves of compounds 2–5 and 7. 
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is observable. In the complex with the two NCS– (7), the decomposition steps are 
clearly separated (see Fig. 2).  
In Fig. 3, the DTG curves of compound without a co-ligand (1) and with a 
coordinated oxoanion (NO2–, 6) are presented together with the corresponding 
curves of the most and the least stable (pseudo)halido complexes (2 and 7). As 
can be seen in Fig. 2, the thermal stability of 1 is by far the highest. The enthalpy 
of its decomposition is about the same as that for 2. The thermal stability and the 
decomposition pattern of 6 with nitrito ligand are similar to the corresponding 
ones in 5. These facts refer to the role of the coordinated anion in decreasing 
thermal stability of the complexes. Moreover, the thermal stability can be related 
to the stability constants of the compounds and is in accordance with the Pearson 
Hard and Soft Acids and Bases (HSAB) principle.35,36 
 
Fig. 3. Comparison of the DTG curves for compounds 1 and 6 with those for 
compounds 2 and 7. 
The thermal stability of the compounds and the corresponding IC50 values 
against HeLa cell line are presented in Fig. 4. As can be seen, the course of the 
curves is very similar and with decreasing thermal stability, the antiproliferative 
activity of the complexes decreases. When comparing the cytotoxic activity of 
the compounds against HeLa cells, it seems as if the dissociation of the molecule 
plays an important role in cytotoxicity. Namely, by dissociation of the co-ligand 
of the compounds 2–7, complex 1 with the highest cytotoxicity is formed. The 
easier is the dissociation, the higher is the activity of the compound. In addition, 
on dissociation a conversion from the boat to the chair conformation is expected. 
As the thermal stability of the compounds depends on the least stable bond in the 
_________________________________________________________________________________________________________________________
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molecule, it could be assumed that the thermal decomposition in complexes 2–7 
starts with the loss of the co-ligand/s*. It could be expected, therefore, that with 
decreasing thermal stability, the cytotoxicity would increase. However, experi-
mental data confirmed just the opposite, i.e., with decreasing thermal stability, 
the cytotoxicity also decreased. This seemingly contradictory observation could 
be explained by changes in the rigidity30b of the complex molecules and/or to 
reduced possibility of H-bond formation by the coordination of the co-ligands. 
Therefore, the conformation of the molecule may significantly affect the inter-
actions of the complexes with HeLa cells. 
 
Fig. 4. Comparison of the thermal stability and the antiproliferative activity of compounds 1–7. 
The activity of the compounds against the human melanoma (Fem-x) and 
human colon carcinoma (LS174) cell lines indicate different reaction routes and 
compound 6 with nitrito co-ligand showed a high selectivity toward LS174 cells.  
CONCLUSIONS 
The significantly higher thermal stability of 1 and its significantly higher 
cytotoxicity could be related to both the electronic and steric factors. Additional 
coordination of the co-ligands decreases the charge on the complex cation. The 
charge distribution in the molecule depends on the co-ligand, and may have a 
role in decreasing antiproliferative activity. In addition, the bridging of the two 
metal centers by one co-ligand modifies the geometry of the entire molecule, and 
the chair conformation of 1 is converted to the boat conformation in the other 
complexes, except in 7 in which the two NCS– ligands are bonded in the trans 
configuration. The decrease in the thermal stability and stability constants of 
                                                                                                                    
* Unfortunately, due to the presence of perchlorates, the rate of the decomposition was too 
high, so the detection of the fragments belonging to the co-ligands was not possible.  
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compounds 2–7 is in accordance with the HSAB principle. However, the cyto-
toxicity of the compounds against the HeLa cell line with decreasing thermal 
stability also decreased, inferring the importance of the steric factors in the inter-
action of the complexes with the target cells. With the other two cell lines, the 
antiproliferative activities of the complexes were lower than that observed for 1, 
except for 6 with a coordinated nitrite ion that exhibits a selective cytotoxicity 
against LS174 cell line that is comparable with the cytotoxicity observed for 1.  
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И З В О Д  
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ДИНУKЛЕАРНИХ Cu(II) КОМПЛЕКСА 
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За седам макроцикличних динуклеарних Cu(II) комплекса са N,N′,N′′,N′′′-тетра-
кис(2-пиридилметил)-1,4,8,11-тетраазациклотетрадеканом (tpmc) формуле [Cu2tpmc] 
(ClO4)4 (1), [Cu2(X)tpmc](ClO4)3·nH2O, X= F-, n = 0 (2), X = Cl-, n = 1 (3), X = Br-, n = 0 (4), 
X= I-, n = 1 (5), X = NO2-, n = 0 (6), [Cu2(NCS)2tpmc](ClO4)2 (7) испитивана је њихова 
цитотоксичност на хуманим малигним ћелијским линијама: цервикалног аденокарци-
нома (HeLa), меланома (Fem-x) и хуманог карцинома дебелог црева (LS174). Резултати 
су упоређени са одговарајућим подацима за cis-диамминдицхлоридоплатину (II) (CDDP) 
као референтним цитостатиком (слободни лиганди и растварач DMSO су били кон-
тролни). Комплекси су показали значајно антипролиферативно дејство, иако знатно 
мање него CDDP. Термичка разградња комплекса је одређена TG/DSC мерењем. Тер-
мичка стабилност једињења 2–7 прати тренд њихове антипролиферативне активности 
према HeLa ћелијској линији, као и њихове одговарајуће константе стабилности. Нај-
већу термичку стабилност и цитотоксичност има комплекс 1 без анјонског колиганда. 
(Примљено 4. априла, ревидирано 15. априла, прихваћено 15. априла 2014) 
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